Sony Group: Bernstein hikes target on gaming, media, and chip prospects
Related Posts
Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…
Europe’s fear of the outsider
Stay informed with free updates Simply sign up to the Life & Arts myFT Digest — delivered directly to your…
Stellantis teams up with China’s CATL to build a $4.3 billion EV factory in Spain—Europe’s second-biggest vehicle producer
They aim to start production by the end of 2026 at the site in the northern city of Zaragoza. Read…